Cardiovascular disease is responsible for one in four premature deaths in the UK and accounts for the largest gap in health life expectancy meaning any new preventative treatments are vital
The UK’s top cardiologist told the conference in Venice that the introduction of semaglutide – sold under the brand names Wegovy and Ozempic – could be the biggest medical breakthrough since statins.
He said anyone with a Body Mass Index of at least 27 – millions of people in the UK – should therefore be recommended semaglutide if they wanted to improve their overall cardiovascular health, not just to target weight loss. Prevalence appears to be higher in areas of greater deprivation and among people with disabilities, lower levels of education or of Black ethnicity. There are more than 11,000 hospital admissions each year directly attributable to obesity.
CVD affects around seven million people in the UK and is a significant cause of disability and death. It is responsible for one in four premature deaths in the UK and accounts for the largest gap in health life expectancy. “Around half of the patients that I see in my cardiovascular practice have levels of weight equivalent to those in the trial and are likely to derive benefit from taking semaglutide on top of their usual level of guideline-directed care,” Professor Deanfield said.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New study shows NHS digital weight management program is effective at achieving clinically meaningful weight lossThe success of a national weight management program has been highlighted in a study in the journal Obesity. The 12-week NHS Digital Weight Management Program gives diet, exercise and lifestyle advice via a phone app or online, to patients referred by their GP with a high BMI plus hypertension, diabetes or both.
Read more »
Millions could ‘slash heart disease risk’ on weight-loss jabs like Wegovy – in ‘biggest breakthrough since...‘Godzilla’ of weight-loss jabs could be ‘best so far – helping slimmers shed 30% body weight’
Read more »
Excessive pregnancy weight gain and substantial postpartum weight retention common in military health care beneficiariesCompared to their civilian counterparts, excessive pregnancy weight gain is more frequent among military health care beneficiaries, in particular active duty personnel, and is associated with costly maternal/neonatal complications.
Read more »
‘Godzilla’ of weight-loss jabs could be ‘best so far – helping slimmers shed 30% body weight’...FILE PHOTO: Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo
Read more »
New rules mean 3.6 million Americans could get Wegovy via Medicare, costing billionsA budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.
Read more »
what are the weight loss injections and what were they designed to do?Weight loss injection Wegovy is available on the NHS for people living with obesity, while Ozempic has become the darling of dieters in the US - despite being designed as a diabetes treatment. Sky News looks at the new wave of weight loss drugs and how they work.
Read more »